Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Georgia

Phase 2 colorectal cancer trials in Georgia

8 Phase 2 colorectal cancer studies are recruiting participants at sites in 5 cities across Georgia as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Georgia city with a recruiting study

Atlanta (6), Decatur (1), Johns Creek (1), Marietta (1), Newnan (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Georgia

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Recruiting in
    Atlanta
    Registry record
    NCT07446322 · updated
  2. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Atlanta
    Registry record
    NCT05673148 · updated
  3. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Marietta
    Registry record
    NCT06820463 · updated
  4. Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Buzzard Pharmaceuticals
    Recruiting in
    Atlanta
    Registry record
    NCT06634875 · updated
  5. Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Recruiting in
    Newnan
    Registry record
    NCT07595874 · updated
  6. Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Recruiting in
    Atlanta · Johns Creek
    Registry record
    NCT07140679 · updated
  7. Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Endevica Bio
    Recruiting in
    Atlanta
    Registry record
    NCT06937177 · updated
  8. Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Recruiting in
    Atlanta · Decatur
    Registry record
    NCT07405476 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Georgia on ClinicalTrials.gov.

Ask about studies in Georgia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call